ArQule Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.7B

  • Investors
  • 1

ArQule General Information

Description

Developer of targeted therapeutics to treat cancers and certain rare diseases. The company commercializes novel small molecule drugs in biomarker-defined oncology and rare disease indications, enabling patients to extend and improve their lives.

Contact Information

Website
www.arqule.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Wall Street
  • Burlington, MA 01803
  • United States
+1 (781)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Merck & Co.
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • One Wall Street
  • Burlington, MA 01803
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ArQule Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 16-Jan-2020 $2.7B Completed Profitable
6. 2PO 13-Jul-2018 Completed Profitable
5. PIPE 08-Nov-2017 Completed Profitable
4. PIPE 01-Jan-1999 Completed Generating Revenue
3. IPO 16-Oct-1996 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Nov-1995 $2.4M $9.4M Completed Generating Revenue
1. Early Stage VC (Series B) 01-Nov-1995 $7M $7M Completed Generating Revenue
To view ArQule’s complete valuation and funding history, request access »

ArQule Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted therapeutics to treat cancers and certain rare diseases. The company commercializes novel small mo
Drug Discovery
Burlington, MA
24 As of 2019

Tokyo, Japan
 

Raritan, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ArQule Competitors (40)

One of ArQule’s 40 competitors is Astellas Pharma, a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astellas Pharma Corporation Tokyo, Japan
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
Genentech Formerly VC-backed South San Francisco, CA
Emmaus Life Sciences Formerly VC-backed Torrance, CA
Centrose Venture Capital-Backed Madison, WI
You’re viewing 5 of 40 competitors. Get the full list »

ArQule Patents

  • 792

    Total Documents Applications and Grants

  • Total Patents Families

  • 274

    Granted

  • 24

    Pending

  • Expiring in next 12 mo

ArQule Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023242760-A1 Pharmaceutical combinations and methods of use of amino-pyrrolopyrimidinone compound Pending 29-Mar-2022
EP-4499101-A1 Pharmaceutical combinations and methods of use of amino-pyrrolopyrimidinone compound Pending 29-Mar-2022
EP-4499101-A4 Pharmaceutical combinations and methods of use of amino-pyrrolopyrimidinone compound Pending 29-Mar-2022
US-20250170133-A1 Pharmaceutical combinations and methods of use of amino-pyrrolopyrimidinone compound Pending 29-Mar-2022
WO-2023192183-A1 Pharmaceutical combinations and methods of use of amino-pyrrolopyrimidinone compound Inactive 29-Mar-2022 A61K31/519
To view ArQule’s complete patent history, request access »

ArQule Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ArQule Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
ArQule Partners Corporation Minority
Atlas Venture Venture Capital Minority
Gimv PE/Buyout Minority
Medison Ventures Corporate Venture Capital Minority
Physic Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

ArQule Acquisitions (2)

ArQule’s most recent deal was a Merger/Acquisition with Cyclis Pharmaceuticals for . The deal was made on 08-Sep-2003.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cyclis Pharmaceuticals 08-Sep-2003 Merger/Acquisition Drug Discovery
Camitro 01-Feb-2001 Merger/Acquisition Discovery Tools (Healthcare)
To view ArQule’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

ArQule FAQs

  • When was ArQule founded?

    ArQule was founded in 1993.

  • Where is ArQule headquartered?

    ArQule is headquartered in Burlington, MA.

  • What is the size of ArQule?

    ArQule has 24 total employees.

  • What industry is ArQule in?

    ArQule’s primary industry is Drug Discovery.

  • Is ArQule a private or public company?

    ArQule is a Private company.

  • What is the current valuation of ArQule?

    The current valuation of ArQule is .

  • What is ArQule’s current revenue?

    The current revenue for ArQule is .

  • How much funding has ArQule raised over time?

    ArQule has raised $48.9M.

  • Who are ArQule’s investors?

    ArQule Partners, Atlas Venture, Gimv, Medison Ventures, and Physic are 5 of 7 investors who have invested in ArQule.

  • Who are ArQule’s competitors?

    Astellas Pharma, Johnson&Johnson Innovative Medicine, Genentech, Emmaus Life Sciences, and Centrose are some of the 40 competitors of ArQule.

  • When was ArQule acquired?

    ArQule was acquired on 16-Jan-2020.

  • Who acquired ArQule?

    ArQule was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process